Expression of second class of KIP protein p57KIP2 in human colorectal carcinoma

被引:3
作者
Noura, S
Yamamoto, H
Sekimoto, M
Takemasa, I
Miyake, Y
Ikenaga, M
Matsuura, N
Monden, M
机构
[1] Osaka Univ, Grad Sch Med, Dept Surg & Clin Oncol, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Fac Med, Sch Allied Hlth Sci, Dept Pathol, Suita, Osaka 5650871, Japan
关键词
colorectal cancer; p57(KIP2); immunohistochemistry; RT-PCR; prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p57(KIP2), the second class of KIP family protein, is one of the negative regulators of the cell cycle. To elucidate the role of p57(KIP2) in colorectal normal mucosa and cancer, we examined the expression of p57(KIP2) protein in 110 pairs of colorectal non-tumor and cancer tissues. Immunohistochemical analysis showed that p57(KIP2) was weakly detected in the normal colonic epithelium and lymph follicles. A unique expression pattern of p57(KIP2) was exclusively noted in the elastic fibers within the walls of relatively large blood vessels (diameter >100 mum). In cancer tissues, p57(KIP2) protein was localized mainly in nuclei. Using the mean percentage of nuclear p57(KIP2) expression (25%) as the cut-off value, we divided our cases into those with high expression (n= 44, 40%) and low expression (n=66, 60%) of p57(KIP2) among 110 colorectal cancer cases tested. The clinical and pathological survey showed a significant correlation between low expression of p57(KIP2) and large tumor size (p <0.05) or the presence of tumors in females (p<0.01). Survival analysis showed that p57(KIP2) expression did not influence prognosis. RT-PCR analysis was also performed using RNA extracts from 6 colorectal cancer tissues. When the levels of p57(KIP2) mRNAs were compared with expression of p57(KIP2) protein, a clear correlation was found, suggesting that expression of the p57(KIP2) protein may be regulated at the transcription level. The present study revealed p57(KIP2) expression in colorectal cancer and suggests that p57(KlP2),ay not play a central role in the progression of colorectal cancer.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 50 条
[1]   Decreased levels of the cell-cycle inhibitor p27(Kip1) protein: Prognostic implications in primary breast cancer [J].
Catzavelos, C ;
Bhatacharya, N ;
Ung, YC ;
Wilson, JA ;
Roncari, L ;
Sandhu, C ;
Shaw, P ;
Yeger, H ;
MoravaProtzner, I ;
Kapusta, L ;
Franssen, E ;
Pritchard, KI ;
Slingerland, JM .
NATURE MEDICINE, 1997, 3 (02) :227-230
[2]  
Ciaparrone M, 1998, CANCER RES, V58, P114
[3]   THE UBIQUITIN-PROTEASOME PROTEOLYTIC PATHWAY [J].
CIECHANOVER, A .
CELL, 1994, 79 (01) :13-21
[4]   Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation [J].
Clurman, BE ;
Sheaff, RJ ;
Thress, K ;
Groudine, M ;
Roberts, JM .
GENES & DEVELOPMENT, 1996, 10 (16) :1979-1990
[5]   New insights into the tumor suppression function of P27Kip1 [J].
Clurman, BE ;
Porter, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15158-15160
[6]   Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquintin-proteasome pathway [J].
Diehl, JA ;
Zindy, F ;
Sherr, CJ .
GENES & DEVELOPMENT, 1997, 11 (08) :957-972
[7]  
Doglioni C, 1996, J PATHOL, V179, P248, DOI 10.1002/(SICI)1096-9896(199607)179:3<248::AID-PATH571>3.0.CO
[8]  
2-6
[9]  
Gomyo Y, 1997, CANCER, V79, P2067, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2067::AID-CNCR3>3.0.CO
[10]  
2-M